chr6-7579663-T-TA
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000379802.8(DSP):c.3474dup(p.Glu1159ArgfsTer3) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,732 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )
Consequence
DSP
ENST00000379802.8 frameshift
ENST00000379802.8 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.128
Genes affected
DSP (HGNC:3052): (desmoplakin) This gene encodes a protein that anchors intermediate filaments to desmosomal plaques and forms an obligate component of functional desmosomes. Mutations in this gene are the cause of several cardiomyopathies and keratodermas, including skin fragility-woolly hair syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-7579663-T-TA is Pathogenic according to our data. Variant chr6-7579663-T-TA is described in ClinVar as [Pathogenic]. Clinvar id is 517147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.3474dup | p.Glu1159ArgfsTer3 | frameshift_variant | 23/24 | ENST00000379802.8 | NP_004406.2 | |
DSP | NM_001008844.3 | c.3474dup | p.Glu1159ArgfsTer3 | frameshift_variant | 23/24 | NP_001008844.1 | ||
DSP | NM_001319034.2 | c.3474dup | p.Glu1159ArgfsTer3 | frameshift_variant | 23/24 | NP_001305963.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.3474dup | p.Glu1159ArgfsTer3 | frameshift_variant | 23/24 | 1 | NM_004415.4 | ENSP00000369129 | P2 | |
DSP | ENST00000418664.2 | c.3474dup | p.Glu1159ArgfsTer3 | frameshift_variant | 23/24 | 1 | ENSP00000396591 | A2 | ||
DSP | ENST00000710359.1 | c.3474dup | p.Glu1159ArgfsTer3 | frameshift_variant | 23/24 | ENSP00000518230 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461732Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727152
GnomAD4 exome
AF:
AC:
1
AN:
1461732
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
727152
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 21, 2022 | This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 517147). This premature translational stop signal has been observed in individual(s) with clinical features of DSP-related conditions (PMID: 31386562, 32372669). This sequence change creates a premature translational stop signal (p.Glu1159Argfs*3) in the DSP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DSP are known to be pathogenic (PMID: 20716751, 24503780, 25227139). - |
Primary dilated cardiomyopathy;C0349788:Arrhythmogenic right ventricular cardiomyopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 31, 2018 | The p.Glu1159fs variant in DSP has been identified in 2 individuals with ARVC an d 1 individual with DCM. It segregated with disease in 5 affected family members from 2 families (Asimaki 2016, LMM data). It was absent from large population s tudies. This variant is predicted to cause a frameshift, which alters the protei n?s amino acid sequence beginning at position 1159 and leads to a premature term ination codon 2 amino acids downstream. This alteration is then predicted to lea d to a truncated or absent protein. Heterozygous loss of function of the DSP gen e is associated with ARVC and DCM. In summary, this variant meets criteria to be classified as pathogenic for ARVC and DCM in an autosomal dominant manner based upon its loss of function impact, case observations, segregation studies, and a bsence from controls. ACMG/AMP Criteria applied: PVS1; PM2; PP1_Moderate; PS4_Su pporting. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 22, 2018 | The c.3474dupA pathogenic mutation, located in coding exon 23 of the DSP gene, results from a duplication of A at nucleotide position 3474, causing a translational frameshift with a predicted alternate stop codon (p.E1159Rfs*3). This alteration has been detected in an arrhythmogenic right ventricular cardiomyopathy (ARVC) cohort (Asimaki A et al. Circ Arrhythm Electrophysiol, 2016 Feb;9:e003688). Alterations in DSP that result in haploinsufficiency or protein truncation have been reported in patients with ARVC and dilated cardiomyopathy (DCM) (Fressart V et al. Europace. 2010;12(6):861-8; Elliott P et al. Circ Cardiovasc Genet. 2010;3(4):314-22; Quarta G et al. Circulation. 2011;123(23):2701-9; Garcia-Pavia P et al. Heart. 2011;97(21):1744-52; Rasmussen TB et al. Clin Genet. 2013;84(1):20-30; Pugh TJ et al. Genet Med. 2014;16(8):601-8). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at